Overview

Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
0
Participant gender:
All
Summary
A study of the safety and pharmacokinetics of solithromycin capsules in adolescents
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Cempra Inc
Melinta Therapeutics, Inc.
Collaborator:
Department of Health and Human Services
Treatments:
Solithromycin
Criteria
Inclusion Criteria:

- 12 to 17 yo male or female with suspected or confirmed bacterial infection

Exclusion Criteria:

- Bacterial meningitis

- Clinical significant concomitant medical condition